GIPM
MIRO

G2 Investment Partners Management’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

G2 Investment Partners Management’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-168,723
Closed -$221K – 119
2023
Q3 		$221K Sell
168,723
-12,077
-7% -$17.6K 0.05% 79
2023
Q2 		$316K Sell
180,800
-58,088
-24% -$76.6K 0.08% 82
2023
Q1 		$401K Sell
238,888
-187,874
-44% -$488K 0.11% 82
2022
Q4 		$1.28M Sell
426,762
-58,438
-12% -$229K 0.38% 56
2022
Q3 		$2.13M Sell
485,200
-54,311
-10% -$175K 0.66% 44
2022
Q2 		$2.15M Sell
539,511
-53,793
-9% -$206K 0.69% 41
2022
Q1 		$2.35M Sell
593,304
-91,674
-13% -$342K 0.56% 49
2021
Q4 		$3.21M Buy
684,978
+5,008
+0.7% +$35.6K 0.55% 48
2021
Q3 		$4.73M Buy
679,970
+70,850
+12% +$668K 0.82% 39
2021
Q2 		$7.1M Buy
+609,120
New +$7.84M 1.17% 34

G2 Investment Partners Management's MIRO Position: Q4 2023 in Review

G2 Investment Partners Management sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 168,723 shares — an estimated $221K sold.

G2 Investment Partners Management first reported a position in MIRO in Q2 2021 and held it in 10 quarters. The position peaked at $7.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • G2 Investment Partners Management reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • G2 Investment Partners Management sold 168,723 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $221K.
  • G2 Investment Partners Management first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • G2 Investment Partners Management's Miromatrix Medical Inc. Common Stock position peaked at $7.1M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on G2 Investment Partners Management's 13F filing for Q4 2023, filed 14 Feb 2024.